Chengdu Easton Biopharmaceuticals Co Ltd

SSE:688513

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Chengdu Easton Biopharmaceuticals Co Ltd's stock price target?

Price Target

62.85 CNY

According to Wall Street analysts, the average 1-year price target for Chengdu Easton Biopharmaceuticals Co Ltd is 62.85 CNY with a low forecast of 62.24 CNY and a high forecast of 64.7 CNY.

What is Chengdu Easton Biopharmaceuticals Co Ltd's Revenue forecast?

Projected CAGR

17%

For the last 4 years the compound annual growth rate for Chengdu Easton Biopharmaceuticals Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 17%.

What is Chengdu Easton Biopharmaceuticals Co Ltd's Operating Income forecast?

Projected CAGR

9%

For the last 4 years the compound annual growth rate for Chengdu Easton Biopharmaceuticals Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 9%.

What is Chengdu Easton Biopharmaceuticals Co Ltd's Net Income forecast?

Projected CAGR

16%

For the last 4 years the compound annual growth rate for Chengdu Easton Biopharmaceuticals Co Ltd's net income is 16%. The projected CAGR for the next 3 years is 16%.